Axes 1–2
Traceability and studiedness
Scored from the available data. Identity: A commercial strain code is printed. Quantity disclosure: 0.0%. Potency: Potency is stated at manufacture.
product · release 2026-09-20
XYMOGEN Lacidofil
Structured fields rendered from the release dataset. Unknown values retain a reason; price is outside GIS.
Organisms, fibers and substances on this label
Printed organisms · observed
Organism list
Quantities reflect printed organism rows.
| Printed name and notes | Normalized organism | Printed code | Printed deposit | Printed quantity | Flags |
|---|---|---|---|---|---|
| Lacidofil Blend | not printed | not printed | 49.4 mg | T4; observed; quantity printed | |
| Lactobacillus rhamnosus Rosell-11 | Lacticaseibacillus rhamnosus | Rosell-11 | not printed | not printed | T3; observed; quantity unavailable |
| Lactobacillus helveticus Rosell-52 | Lactobacillus helveticus | Rosell-52 | not printed | not printed | T3; observed; quantity unavailable |
Pack, dose and cost
What the label says beyond the organisms
- Pack
- 84 Capsule(s) · Capsule
- Serving
- 2 Capsule(s) · 3 serving(s) a day
- Days of supply
- 14
- Potency per day
- undefined: no numeric quantity printed
- Cost per day
- no observed price in this release
- Printed claims
- 2 on the label (All Other, Structure/Function). A printed claim is not evidence and does not enter any axis.
- Other ingredients
- 4 printed: Maltodextrin, Gelatin, Magnesium Stearate, Ascorbic Acid
- Label target groups
- Adult (18 - 50 Years), Gluten Free
- Suggested use
- Directions: Take one to two capsules one to three times a day, or as directed by your healthcare practitioner.
- UPC
- 8 71149 00023 3
Printed potency
Quantity on the label
No numeric quantity is printed on 3 organism rows of the latest observed label; potency basis Potency is stated at manufacture. 3 rows sit inside a proprietary blend, so their individual amounts are not disclosed.
Evidence behind the label
Located human trials per organism
| Organism on this label | PubMed records indexed as human randomized controlled trials |
|---|---|
| Lacticaseibacillus rhamnosus | 465 |
| Lacticaseibacillus rhamnosus Rosell-11 | 2 |
| Lactobacillus helveticus | 59 |
| Lactobacillus helveticus Rosell-52 | 3 |
Counts describe records matching each organism's published query, including trials of multi-ingredient products; they are not a count of trials of this product.
Context
Where this score sits
This formulation scores above 41.1% of the 4,101 scored formulations in this release. The score is a preference-dependent summary of the axes, not a health claim.
| Other products carrying the same strain | Shared strain | Gut Index Score | Observed price |
|---|---|---|---|
| XYMOGEN Probio Defense | Rosell-11 | 84.03 | not observed |
| NuMedica Tri-Flora Plus | Rosell-11 | 75.81 | not observed |
| Ombre Metabolic Booster | Rosell-11 | 61.75 | not observed |
A149.50
A274.72
GIS63.37
Axes 3–4
Measurement and brand panel
Not a measurement product, so this axis does not apply.
No brand review panel is published in this release.
Price column
Observed price
undefined: no permitted price observation in this release
Sensitivity
Preference-dependent summary
Preference interval 65.91–70.68; rank uncertainty 713.00–2885.05; rank class 2.
Versions
Typed label snapshot edges
- 28030 → 66145: snapshot comparison. organisms added: Lacidofil Blend, Lactobacillus helveticus Rosell-52, Lactobacillus rhamnosus Rosell-11. organisms removed: Lactobacillus helveticus Rosell-52 and Lactobacillus rhamnosus Rosell-11. potency basis unstated → at_manufacture.
- 28030 → 66145: snapshot comparison. organisms added: Lacidofil Blend, Lactobacillus helveticus Rosell-52, Lactobacillus rhamnosus Rosell-11. organisms removed: Lactobacillus helveticus Rosell-52 and Lactobacillus rhamnosus Rosell-11. potency basis unstated → at_manufacture.
- 28030 → 66145: snapshot comparison. organisms added: Lacidofil Blend, Lactobacillus helveticus Rosell-52, Lactobacillus rhamnosus Rosell-11. organisms removed: Lactobacillus helveticus Rosell-52 and Lactobacillus rhamnosus Rosell-11. potency basis unstated → at_manufacture.
- 28030 → 66145: snapshot comparison. organisms added: Lacidofil Blend, Lactobacillus helveticus Rosell-52, Lactobacillus rhamnosus Rosell-11. organisms removed: Lactobacillus helveticus Rosell-52 and Lactobacillus rhamnosus Rosell-11. potency basis unstated → at_manufacture.
- 6607 → 66145: snapshot comparison. One of these two snapshots carries no parsed ingredient rows, so the formulas cannot be compared. The registry states no change here rather than reading the whole formula as newly added.
- 92996 → 66145: snapshot comparison. One of these two snapshots carries no parsed ingredient rows, so the formulas cannot be compared. The registry states no change here rather than reading the whole formula as newly added.
Preference tool
Weights slider
The readout recomputes the arithmetic summary from the published component JSON. Axis fields remain primary.
Brand: XYMOGEN — every published product of this brand, its potency basis and its observed reformulations.
Elsewhere in this release
Related pages
Findings computed over the whole corpus: Potency basis census · Strain dose match · Supplier code network
Tools: Unit value calculator · DSLD product check
Citation
Cite this page
Ivitskiy, I. (2026). XYMOGEN Lacidofil. Gut Registry, release 2026-09-20. Elanvale Ltd. https://gutregistry.com/p/lacidofil/
The underlying tables are published under CC BY 4.0: this page as CSV · as JSON · full release and data dictionary. Cell-level provenance names the source record and its observation date.
Citable atoms
Release claims
XYMOGEN Lacidofil: 2 of 3 observed organisms name a strain, and 0 print a deposit identifier. Latest observed label 66145. Window: NIH DSLD snapshot Sep 2026.
2 / 3 observed organisms · NIH DSLD snapshot Sep 2026 · product.organisms · checked 2026-09-20T00:00:00Z · snapshot b7633f732437XYMOGEN Lacidofil: 1 of 2 observed label snapshots state a potency basis; latest basis is at manufacture. Quantities reflect printed organism rows. Window: NIH DSLD snapshot Sep 2026.
1 / 2 observed label snapshots · NIH DSLD snapshot Sep 2026 · product.potency · checked 2026-09-20T00:00:00Z · snapshot b7633f732437XYMOGEN Lacidofil: 1 of 1 selected label snapshots have a numeric Gut Index Score; GIS 63.37 on the 100-point scale; rank class 2 of 4 across 3,279 scored formulations; nominal weights varied from 80.0% to 120.0% in preference sensitivity. Window: NIH DSLD snapshot Sep 2026.
1 / 1 selected label snapshots · NIH DSLD snapshot Sep 2026 · product.gis · checked 2026-09-20T00:00:00Z · snapshot b7633f732437XYMOGEN Lacidofil has 2 observed versions across 1 formulation groups; last recorded edge type: available at the same time. Window: NIH DSLD snapshot Sep 2026.
2 / 1 formulation groups · NIH DSLD snapshot Sep 2026 · product.versions · checked 2026-09-20T00:00:00Z · snapshot b7633f732437XYMOGEN Lacidofil: 0 of 2 observed versions have numeric prices; latest price No numeric price observation is available in this release.. Window: NIH DSLD snapshot Sep 2026.
0 / 2 observed label versions · NIH DSLD snapshot Sep 2026 · product.price · checked 2026-09-20T00:00:00Z · snapshot b7633f732437